0001209191-23-020480.txt : 20230322 0001209191-23-020480.hdr.sgml : 20230322 20230322160315 ACCESSION NUMBER: 0001209191-23-020480 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230320 FILED AS OF DATE: 20230322 DATE AS OF CHANGE: 20230322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEPORE PATRICK G CENTRAL INDEX KEY: 0001055404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 23752904 MAIL ADDRESS: STREET 1: 17-17 ROUTE 208 N CITY: FAIRLAWN STATE: NJ ZIP: 07410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VYNE Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206, SUITE 301A CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 800-775-7936 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206, SUITE 301A CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-20 0 0001566044 VYNE Therapeutics Inc. VYNE 0001055404 LEPORE PATRICK G C/O VYNE THERAPEUTICS INC. 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807 1 0 0 0 0 Common Stock 2023-03-20 4 P 0 20000 2.484 A 23472 D The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.464 to $2.5199, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split. /s/ Mutya Harsch, as attorney-in-fact for Patrick G. LePore 2023-03-22